1. Executive Summary |
2. Global Intravenous Solutions Market Introduction |
2.1. Global Intravenous Solutions Market – Taxonomy |
2.2. Global Intravenous Solutions Market –Definitions |
2.2.1. By Solution Type |
2.2.2. By Bag Type |
2.2.3. By Application |
3. Global Intravenous Solutions Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Global Intravenous Solutions Market Dynamic Factors – Impact Analysis |
4. Global Intravenous Solutions Market Analysis,2017 – 2021 and Forecast, 2022 – 2028 |
4.1. Market Analysis,2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Intravenous Solutions Market, By Solution Type, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.1. Normal Saline (0.9% NaCl) |
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Hypertonic Saline |
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Dextran |
5.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Lactated Ringer’s |
5.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. Amino Acid |
5.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
5.6. Vitamins & Minerals |
5.6.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.6.3. Market Opportunity Analysis |
5.7. Heparin and Trace Elements |
5.7.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.7.3. Market Opportunity Analysis |
5.8. Mixed Solutions |
5.8.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.8.3. Market Opportunity Analysis |
6. Global Intravenous Solutions Market Forecast, By Bag Type, 2017 – 2021 and Forecast, 2020 – 2026 (Revenue, USD Mn) |
6.1. Large Volume Bags |
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Small Volume Bags |
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
7. Global Intravenous Solutions Market Forecast, By Application, 2017 – 2021 and Forecast, 2020 – 2026 (Revenue, USD Mn) |
7.1. Basic IV Solution |
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Nutritional IV Solution |
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Blood IV Solution |
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Drug IV Solution |
7.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Irrigation IV Solution |
7.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
8. Global Intravenous Solutions Market Forecast, By End-user, 2017 – 2021 and Forecast, 2020 – 2026 (Revenue, USD Mn) |
8.1. Hospitals |
8.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Clinics |
8.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Ambulatory Surgery Centers |
8.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Home Care Settings |
8.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
9. Global Intravenous Solutions Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
9.1. North America |
9.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Europe |
9.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Asia-Pacific |
9.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Latin America |
9.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. Middle East and Africa |
9.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.5.3. Market Opportunity Analysis |
9.6. Global Intravenous Solutions Market – Opportunity Analysis Index, By Solution Type, By Bag Type, By Application, End-user and Region, 2022 – 2028 |
10. North America Intravenous SolutionsMarketAnalysis,2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
10.1. Solution Type Analysis 2017 – 2021 and Forecast 2022 – 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Normal Saline (0.9% NaCl) |
10.1.2. Hypertonic Saline |
10.1.3. Dextran |
10.1.4. Lactated Ringer’s |
10.1.5. Amino Acid |
10.1.6. Vitamins & Minerals |
10.1.7. Heparin and Trace Elements |
10.1.8. Mixed Solutions |
10.2. Bag Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.2.1. Large Volume Bags |
10.2.2. Small Volume Bags |
10.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.3.1. Basic IV Solution |
10.3.2. Nutritional IV Solution |
10.3.3. Blood IV Solution |
10.3.4. Drug IV Solution |
10.3.5. Irrigation IV Solution |
10.4. End-user Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.4.1. Hospitals |
10.4.2. Clinics |
10.4.3. Ambulatory Surgery Centers |
10.4.4. Home Care Settings |
10.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
10.5.1. USA |
10.5.2. Canada |
10.6. North America Intravenous Solutions Market – Opportunity Analysis Index, By Solution Type, By Bag Type, By Application and Country, 2022 – 2028 |
10.7. North America Intravenous Solutions Market Dynamics – Trends |
11. Europe Intravenous Solutions Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
11.1. Solution Type Analysis 2017 – 2021 and Forecast 2022 – 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Normal Saline (0.9% NaCl) |
11.1.2. Hypertonic Saline |
11.1.3. Dextran |
11.1.4. Lactated Ringer’s |
11.1.5. Amino Acid |
11.1.6. Vitamins & Minerals |
11.1.7. Heparin and Trace Elements |
11.1.8. Mixed Solutions |
11.2. Bag Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.2.1. Large Volume Bags |
11.2.2. Small Volume Bags |
11.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.3.1. Basic IV Solution |
11.3.2. Nutritional IV Solution |
11.3.3. Blood IV Solution |
11.3.4. Drug IV Solution |
11.3.5. Irrigation IV Solution |
11.4. End-user Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.4.1. Hospitals |
11.4.2. Clinics |
11.4.3. Ambulatory Surgery Centers |
11.4.4. Home Care Settings |
11.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
11.5.1. Germany |
11.5.2. UK |
11.5.3. France |
11.5.4. Spain |
11.5.5. Italy |
11.5.6. Russia |
11.5.7. Poland |
11.5.8. Rest of Europe |
11.6. Europe Intravenous Solutions Market – Opportunity Analysis Index, By Solution Type, By Bag Type, By Application and Country,2022 – 2028 |
11.7. Europe Intravenous Solutions Market Dynamics – Trends |
12. Asia-Pacific Intravenous Solutions Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
12.1. Solution Type Analysis 2017 – 2021 and Forecast 2022 – 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
12.1.1. Normal Saline (0.9% NaCl) |
12.1.2. Hypertonic Saline |
12.1.3. Dextran |
12.1.4. Lactated Ringer’s |
12.1.5. Amino Acid |
12.1.6. Vitamins & Minerals |
12.1.7. Heparin and Trace Elements |
12.1.8. Mixed Solutions |
12.2. Bag Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.2.1. Large Volume Bags |
12.2.2. Small Volume Bags |
12.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.3.1. Basic IV Solution |
12.3.2. Nutritional IV Solution |
12.3.3. Blood IV Solution |
12.3.4. Drug IV Solution |
12.3.5. Irrigation IV Solution |
12.4. End-user Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.4.1. Hospitals |
12.4.2. Clinics |
12.4.3. Ambulatory Surgery Centers |
12.4.4. Home Care Settings |
12.5. Country Analysis2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
12.5.1. Japan |
12.5.2. China |
12.5.3. India |
12.5.4. ASEAN |
12.5.5. Australia & New Zealand |
12.5.6. Rest of Asia-Pacific |
12.6. Asia-Pacific Intravenous Solutions Market – Opportunity Analysis Index, By Solution Type, By Bag Type, By Application and Country,2022 – 2028 |
12.7. Asia-Pacific Intravenous Solutions Market Dynamics – Trends |
13. Latin America Intravenous Solutions Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
13.1. Solution Type Analysis 2017 – 2021 and Forecast 2022 – 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
13.1.1. Normal Saline (0.9% NaCl) |
13.1.2. Hypertonic Saline |
13.1.3. Dextran |
13.1.4. Lactated Ringer’s |
13.1.5. Amino Acid |
13.1.6. Vitamins & Minerals |
13.1.7. Heparin and Trace Elements |
13.1.8. Mixed Solutions |
13.2. Bag Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.2.1. Large Volume Bags |
13.2.2. Small Volume Bags |
13.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.3.1. Basic IV Solution |
13.3.2. Nutritional IV Solution |
13.3.3. Blood IV Solution |
13.3.4. Drug IV Solution |
13.3.5. Irrigation IV Solution |
13.4. End-user Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.4.1. Hospitals |
13.4.2. Clinics |
13.4.3. Ambulatory Surgery Centers |
13.4.4. Home Care Settings |
13.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
13.5.1. Brazil |
13.5.2. Mexico |
13.5.3. Argentina |
13.5.4. Rest of Latin America |
13.6. Latin America Intravenous Solutions Market – Opportunity Analysis Index, By Solution Type, By Bag Type, By Application and Country,2022 – 2028 |
13.7. Latin America Intravenous Solutions Market Dynamics – Trends |
14. Middle East and Africa Intravenous Solutions Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
14.1. Solution Type Analysis 2017 – 2021 and Forecast 2022 – 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
14.1.1. Normal Saline (0.9% NaCl) |
14.1.2. Hypertonic Saline |
14.1.3. Dextran |
14.1.4. Lactated Ringer’s |
14.1.5. Amino Acid |
14.1.6. Vitamins & Minerals |
14.1.7. Heparin and Trace Elements |
14.1.8. Mixed Solutions |
14.2. Bag Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.2.1. Large Volume Bags |
14.2.2. Small Volume Bags |
14.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.3.1. Basic IV Solution |
14.3.2. Nutritional IV Solution |
14.3.3. Blood IV Solution |
14.3.4. Drug IV Solution |
14.3.5. Irrigation IV Solution |
14.4. End-user Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.4.1. Hospitals |
14.4.2. Clinics |
14.4.3. Ambulatory Surgery Centers |
14.4.4. Home Care Settings |
14.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
14.5.1. Gulf Cooperation Council (GCC) Countries |
14.5.2. Israel |
14.5.3. South Africa |
14.5.4. Rest of MEA |
14.6. MEA Intravenous Solutions Market – Opportunity Analysis Index, By Solution Type, By Bag Type, By Application and Country,2022 – 2028 |
14.7. MEA Intravenous Solutions Market Dynamics – Trends |
15. Competition Landscape |
15.1. Strategic Dashboard of Top Market Players |
15.2. Company Profiles (Introduction, Financial Analysis, Bag Type& Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
15.2.1. Baxter International Inc. |
15.2.2. ICU Medical, Inc. |
15.2.3. B. Braun Melsungen Ag |
15.2.4. Grifols, S.A. |
15.2.5. Fresenius Kabi USA, LLC |
15.2.6. Vifor Pharma Management Ltd. |
15.2.7. JW Life Science |
15.2.8. Amanta Healthcare |
15.2.9. Axa Parenterals Ltd. |
15.2.10. Salius Pharma Private Limited. |
16. Research Methodology |
17. Key Assumptions and Acronyms |
Reviews
There are no reviews yet.